Study of JK07 in Patients With Chronic Heart Failure

PHASE2RecruitingINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction
Interventions
DRUG

JK07

JK07 is a fully human anti-human epidermal growth factor receptor 3 (also known as ErbB3 or HER3) antibody fused with the epidermal growth factor (EGF)-domain of Neuregulin (NRG)-1b protein.

DRUG

Placebo

0.9% sodium chloride

Trial Locations (62)

10595

RECRUITING

Site 153, Valhalla

17403

RECRUITING

Site 155, York

21201

RECRUITING

Site 118, Baltimore

22042

RECRUITING

Site 123, Falls Church

22182

RECRUITING

Site 163, Vienna

22205

RECRUITING

Site 148, Arlington

23507

RECRUITING

Site 126, Norfolk

27518

RECRUITING

Site 109, Cary

27710

RECRUITING

Site 145, Durham

28204

RECRUITING

Site 140, Charlotte

28803

RECRUITING

Site 152, Asheville

30343

RECRUITING

Site 136, Atlanta

33014

RECRUITING

Site 162, Miami Lakes

33016

RECRUITING

Site 114, Hialeah

33134

RECRUITING

Site 161, Coral Gables

34104

RECRUITING

Site 159, Naples

35010

RECRUITING

Site 121, Alexander City

35211

RECRUITING

Site 130, Birmingham

35294

RECRUITING

Site 139, Birmingham

35801

RECRUITING

Site 138, Huntsville

44195

RECRUITING

Site 100, Cleveland

45219

RECRUITING

Site 117, Cincinnati

46250

RECRUITING

Site 112, Indianapolis

46804

RECRUITING

Site 137, Fort Wayne

48304

RECRUITING

Site 122, Bloomfield Hills

48334

RECRUITING

Site 150, Farmington Hills

55905

RECRUITING

Site 107, Rochester

60068

RECRUITING

Site 154, Park Ridge

60611

RECRUITING

Site 160, Chicago

63110

RECRUITING

Site 106, St Louis

63136

RECRUITING

Site 105, St Louis

70433

RECRUITING

Site 104, Covington

72205

RECRUITING

Site 127, Little Rock

73135

RECRUITING

Site 135, Oklahoma City

75235

RECRUITING

Site 110, Dallas

75246

RECRUITING

Site 115, Dallas

77030

RECRUITING

Site 103, Houston

77375

RECRUITING

Site 149, Tomball

83712

RECRUITING

Site 143, Boise

85016

RECRUITING

Site 111, Phoenix

90033

RECRUITING

Site 157, Los Angeles

90502

RECRUITING

Site 113, Torrance

91105

RECRUITING

Site 116, Pasadena

92081

RECRUITING

Site 133, Vista

92648

RECRUITING

Site 128, Huntington Beach

92868

RECRUITING

Site 158, Orange

93454

RECRUITING

Site 129, Santa Maria

94305

RECRUITING

Site 102, Stanford

97239

RECRUITING

Site 101, Portland

100037

RECRUITING

Site 300, Beijing

210009

RECRUITING

Site 303, Nanjing

272100

RECRUITING

Site 306, Jining

404000

RECRUITING

Site 304, Chongqing

410005

RECRUITING

Site 305, Changsha

610041

RECRUITING

Site 301, Chengdu

02114

RECRUITING

Site 119, Boston

08724

RECRUITING

Site 144, Brick

R2H2A6

RECRUITING

Site 202, Winnepeg

L6Z 4N5

RECRUITING

Site 203, Brampton

G7H 7K9

RECRUITING

Site 200, Chicoutimi

G9A 4P3

RECRUITING

Site 201, Trois-Rivières

00717

RECRUITING

Site 156, Ponce

All Listed Sponsors
lead

Salubris Biotherapeutics Inc

INDUSTRY

NCT06369298 - Study of JK07 in Patients With Chronic Heart Failure | Biotech Hunter | Biotech Hunter